← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2002Last known activity
Dec 6, 2024
Timeline
1910s
- Jan 1, 1911
Kwong Wah Hospital— Founded
Drugs by trial phase (19 distinct, 14 trials)
Phase 4 (9 own, 0 via acquisition)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Indications
Studied for
- Alzheimer Disease
- Aneurysm
- Bone Diseases, Metabolic
- Brain Ischemia
- Cerebral Hemorrhage
- Cerebral Infarction
- Communicable Diseases
- Hemorrhage
- Infections
- Infertility
- Intracranial Aneurysm
- Ischemia
- Lung Diseases, Obstructive
- Muscular Diseases
- Mycobacterium Infections
- Mycobacterium Infections, Nontuberculous
- Myositis
- Osteoporosis
- Peptic Ulcer
- Peptic Ulcer Hemorrhage
- Pulmonary Disease, Chronic Obstructive
- Subarachnoid Hemorrhage
Recent trials (26)
- NCT06733727CollaboratorN/ADec 6, 2024
- NCT05487092CollaboratorN/ADec 1, 2022
- NCT04547530CollaboratorPhase 4Jan 2, 2021
- NCT04650880CollaboratorN/AJan 2, 2021
- NCT04034199CollaboratorPhase 3Aug 15, 2019
- NCT04034199Lead sponsorPhase 3Aug 15, 2019
- NCT04034199Reponsible party - principal investigatorPhase 3Aug 15, 2019
- NCT03671707CollaboratorN/AOct 1, 2018
- NCT03044184Lead sponsorPhase 3Apr 1, 2017
- NCT03044184Reponsible party - principal investigatorPhase 3Apr 1, 2017
- NCT03044184Overall official - principal investigatorPhase 3Apr 1, 2017
- NCT02494180Reponsible party - principal investigatorPhase 4Jul 1, 2015
- NCT02494180Lead sponsorPhase 4Jul 1, 2015
- NCT02494180Overall official - principal investigatorPhase 4Jul 1, 2015
- NCT01787123Reponsible party - principal investigatorPhase 2/Phase 3Jun 1, 2013
Details
- Founded
- Hong Kong, HK Jan 1, 1911
- Last known activity
- Dec 6, 2024